RAFAEL HOLDINGS, INC. Convertible Debt, Noncurrent
RAFAEL HOLDINGS, INC. (RFL) had Convertible Debt, Noncurrent of $14.95 million as of 2019-07-31, per its 10-K filed 2020-10-29.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2020-10-29
- 2019-07-31: Convertible Debt, Noncurrent $14.95M.
- 2019-04-30: Convertible Debt, Noncurrent $14.94M.
- 2019-01-31: Convertible Debt, Noncurrent $14.93M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2019-07-31 | $14.95M 10-K · filed 2020-10-29 |
| 2019-04-30 | $14.94M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $14.93M 10-Q · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |